2026 NPPES data Hematology & Oncology Physician NPI 1952729196 MD, MBA
Verify on CMS →

ARISHA PATEL, MD, MBA

Hematology & Oncology Physician in MCKINNEY, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
121
Medicare Part D claims · 28 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$22.84
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ARISHA PATEL, MD, MBA filed 121 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in MCKINNEY, Texas, prescribing 83% generic.

121
Part D claims, 2023
83%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ARISHA PATEL, MD, MBA's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

121 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

ARISHA PATEL, MD, MBA practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ARISHA PATEL, MD, MBA?

Quality data not reported

NPI registry status

Active

Issued 04/04/2014

NPI 1952729196

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

121 86% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Texas

How Hematology & Oncology Physician compares to other specialties among Texas providers

Texas providers

Hematology & Oncology Physician share within Texas

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ARISHA PATEL, MD, MBA appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD, MBA credentials at 1400 N COIT RD STE 302, MCKINNEY, TX, 75071, with a listed phone of (214) 449-1111. NPI 1952729196 was issued on 04/04/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PATEL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 121 prescription claims written by this provider, covering 28 Medicare beneficiaries and totaling roughly $206K in drug spend, split 17% brand-name and 83% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1400 N COIT RD STE 302
MCKINNEY, TX 75071

Provider Details

NPI 1952729196
Specialty Hematology & Oncology Physician
Credentials MD, MBA
Gender Female
NPI Issued 04/04/2014

Hospital and facility affiliations

Facilities where ARISHA PATEL, MD, MBA bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PARKVIEW HEALTH SYSTEM INC
FORT WAYNE, IN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ARISHA PATEL, MD, MBA. Source: openpaymentsdata.cms.gov.

Total received

$23

Largest payer

Pharmacosmos Therapeutics Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to ARISHA PATEL, MD, MBA. To verify ARISHA PATEL, MD, MBA's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ARISHA PATEL, MD, MBA — brand share 17.0%
Specialty average (est.)

17% brand-name claims vs 83% generic, on 121 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

121
Total Claims
$206K
Total Drug Cost
28
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
163
Total Day Supply
4,407
Brand vs Generic
17% brand / 83% generic
Brand Drug Cost
$153K
Generic Drug Cost
$53K

Patient Demographics

Average Patient Age
73.1 years
Avg HCC Risk Score
1.70

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ARISHA PATEL, MD, MBA prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
14
Prednisone
13
Acyclovir
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How ARISHA PATEL, MD, MBA fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

ARISHA PATEL, MD, MBA's 121 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as PATEL.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ARISHA PATEL, MD, MBA's specialty?
ARISHA PATEL, MD, MBA specializes in Hematology & Oncology Physician and practices in MCKINNEY, Texas. Credentials: MD, MBA.
How much does ARISHA PATEL, MD, MBA prescribe under Medicare Part D?
In 2023, ARISHA PATEL, MD, MBA wrote 121 Medicare Part D claims totaling $206K in drug costs for 28 beneficiaries.
Where is ARISHA PATEL, MD, MBA located?
ARISHA PATEL, MD, MBA is located at 1400 N COIT RD STE 302, MCKINNEY, TX, 75071. Phone: (214) 449-1111.
What is ARISHA PATEL, MD, MBA's NPI number?
ARISHA PATEL, MD, MBA's National Provider Identifier (NPI) is 1952729196, issued on 04/04/2014.
Does ARISHA PATEL, MD, MBA prescribe more brand-name or generic drugs?
ARISHA PATEL, MD, MBA's prescribing is 17% brand-name and 83% generic drugs by claim count, with $153K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does ARISHA PATEL, MD, MBA prescribe most often?
Based on 2023 Medicare Part D data, ARISHA PATEL, MD, MBA's most frequently prescribed drugs include Anastrozole, Prednisone, Acyclovir. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ARISHA PATEL, MD, MBA accept Medicare?
ARISHA PATEL, MD, MBA appears in CMS Medicare data with 121 Part D claims and 28 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ARISHA PATEL, MD, MBA's credentials?
ARISHA PATEL, MD, MBA's NPI is 1952729196 with credentials MD, MBA. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology